Skip to main content
Premium Trial:

Request an Annual Quote

Sciex, Protein Metrics Partner on Mass Spec Data Analysis

NEW YORK – Sciex and Protein Metrics said today that they have partnered to more thoroughly connect Protein Metrics' software suite and Sciex's high-resolution accurate mass (HRAM) spectrometry systems.

Specifically, the companies are linking Protein Metrics' Byos protein characterization software with Sciex's X500 Systems in an attempt to create an open data-analysis ecosystem that will allow biopharmaceutical companies to bring therapeutics to market more quickly, the companies noted in a statement.

The partners began integrating their products more than four years ago with Sciex's TripleTOF 5600 and Triple TOF 6600 LC-MS/MS Systems, enabling customers to track quality attributes for batches of therapeutic protein peptide maps and to characterize and quantify post-translational modifications and sequence variants.

"This demonstrates our commitment to providing an open platform that enables researchers to use the processing software of their choice with our instruments," Fraser McLeod, vice president and general manager for software at Sciex, said in a statement. "We look forward to continuing our collaborative partnership with new product launches."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.